Report: Global tissue Dx market could hit $3.5B by 2017

10/25/2013 | BioSpectrum Asia

A Frost & Sullivan report predicts that the global tissue diagnostic market will increase from $2.4 billion last year to $3.5 billion in 2017, with the U.S. and Europe expected to make up about 79% of market share. Equipment sales have been largely affected by reimbursement cuts, hospital consolidation and other factors, but the market is poised for growth starting next year, the report says.

View Full Article in:

BioSpectrum Asia

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC